TABLETS • TABLETS

DYDRIO-20 ER

Dydrogesterone 20mg Extended Release Tablets

Schedule H Prescription Drug
Printed MRP: ₹9,800.00 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
10x1x10
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
DYDRIO-20 ER Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name DYDRIO-20 ER
Active Formulation (Salt) Dydrogesterone 20mg Extended Release Tablets
Dosage Form TABLETS
Packaging Presentation 10x1x10
Therapeutic Category TABLETS
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is DYDRIO-20 ER?

Therapeutic monograph and clinical profile

DYDRIO-20 ER (Dydrogesterone 20mg Extended Release Tablets) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 10x1x10, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Female Infertility / Miscarriage Prevention.

Key Formulation Highlights

Why healthcare professionals recommend DYDRIO-20 ER

WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
DCGI Approved Formulation with Proven Chemical Purity
High Bioavailability & Predictable Pharmacokinetics
Premium Moisture-Proof Protective Packaging
Exclusive Monopoly PCD Pharma Franchise Rights Available

Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Female Infertility / Miscarriage Prevention

Pharmacological Mechanism of Action

How DYDRIO-20 ER acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for DYDRIO-20 ER

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for DYDRIO-20 ER across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding DYDRIO-20 ER

What is DYDRIO-20 ER used for?
DYDRIO-20 ER is prescribed for Female Infertility / Miscarriage Prevention. Always follow physician dosage instructions.
What is the printed packaging and MRP of DYDRIO-20 ER?
The printed packaging is 10x1x10 with an MRP of ₹9,800.00.
How can I get monopoly PCD franchise for DYDRIO-20 ER?
You can request district monopoly rights directly via sales@riomedicahealthcare.com or WhatsApp +91 82229 99973.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.